Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)

Acta Neuropathologica Communications(2025)10.1186/s40478-025-02119-4Source: DataRank Database

Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1) is a research paper published in Acta Neuropathologica Communications (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

0 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Cheng-En Shen,Sabiha Bano,Nandini Shyamala,Alesandra Echeandia Marrero,Khushboo Irshad ORCID

Live enrichment

PubMed:41024279 PMC:PMC12482478 OpenAlex:https://openalex.org/W4414592890

U.S. Department of Defense

Grant: HT9425-23-1-0239

Neurofibromatosis Therapeutic Acceleration Program

Grant: 210112

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Grant: K12HD076244

Cancer Prevention and Research Institute of Texas

Grant: RR210085

Gilbert Family Foundation

Grant: 622030

FWCI

0.00

Citation Percentile

0.3%

goldLicense: cc-by-nc-nd

journalhttps://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-025-02119-4

publisherhttps://actaneurocomms.biomedcentral.com/counter/pdf/10.1186/s40478-025-02119-4

publisherhttps://link.springer.com/content/pdf/10.1186/s40478-025-02119-4.pdf

publisherhttps://link.springer.com/article/10.1186/s40478-025-02119-4/fulltext.html

journalhttps://doi.org/10.1186/s40478-025-02119-4

Fields of Study

Neurofibromatosis and Schwannoma CasesChromatin Remodeling and CancerMeningioma and schwannoma managementHumansNeurofibromatosis 1OligodendrogliaAnimalsNeurofibromin 1Mutation

MeSH Terms

AnimalsHumansMutationNeurofibromatosis 1OligodendrogliaNeurofibromin 1

Keywords

NeurofibromatosisNeurologyLineage (genetic)Neurofibromatosis type INeurofibromatosesCentral nervous systemNervous systemGliomasNeurofibromatosis Type 1Oligodendroglial LineageNeuron-opc CrosstalkOligodendroglial Plasticity

Current states in understanding oligodendroglia-mediated neurological issues in neurofibromatosis type 1 (NF1)

FAIR Checklist

Authors (9)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)